Delivering an extremely low birthweight (ELBW) infant (
Delivering an extremely low birthweight (ELBW) infant (<600 g) when the mother has prolonged premature rupture of membranes can be a technical challenge. C/S is often chosen as the route of delivery because it is assumed to be less traumatic to the fetus than a trial of labor and planned vaginal delivery. When oligohydramnios is present, the uterine cavity can become distorted, making for difficulties in opening the uterus and safely extracting the fetus. Under such circumstances, traumatic injury is not unusual. Blood loss associated with extending the hysterotomy incision can result in maternal morbidity. The case here describes how we facilitate extraction of an ELBW fetus in the setting of oligohydramnios.
Case report A 26-year-old gravida 3, para 1011 presented to labor and delivery at 25 weeks' gestation with a severe headache. Her initial blood pressures were 173/103 and 161/100. Bedside ultrasound revealed severe oligohydramnios (AFI = 4 cm) and a breech fetus with an estimated fetal weight of 550 g. The patient was started on magnesium sulfate and antibiotics, and a course of steroids.
On the third hospital day, a 24-hour urine collection demonstrated a dramatic increase in proteinuria (5.54 g). We decided to deliver when recurrent variable fetal heart rate decelerations were noted later that day.
The neonate was a 460-g female who appeared to have had intrauterine growth restriction. Her Apgar scores were 6 and 7 at 1 and 5 minutes, respectively. The umbilical artery pH was 7.21 with a base deficit of –3.
In the neonatal intensive care unit, the infant was noted to be pink and making spontaneous respiratory efforts. She opened her eyes and had good movement of all four extremities. There was no evidence of trauma. A neonatal head scan taken on the second day of her life was normal. At age 6 months, no traumatic injury of any type had been identified.
Discussion Nitroglycerin-induced relaxation directly reverses fetal entrapment caused by excessive uterine tone and/or activity. Profound and brief relaxation of the myometrium allows for safer manipulation of the fetus. We use nitroglycerin at a dosage of 50 to 500 µg, depending upon the situation. We find that for obstetric applications, it is particularly useful to administer the drug in small (50- to 100-µg) aliquots.1-3 Because of the limited duration of uterine tone, risk of hemorrhage is minimal.4 The rapid onset (30 seconds) and brief duration of action (90 seconds) makes this approach ideal for obstetrical use.
From a clinical point of view, whether a difficult delivery can be anticipated or occurs spontaneously occurs, the approach we've described can benefit both the neonate and the mother. The technique results in less trauma during delivery, which is obviously one of the goals of C/S.
CLINICIAN to CLINICIAN offers the hard-won wisdom and expertise of physicians "in the trenches." We’re looking for unusual case reports, anecdotes about innovative treatments, and practical solutions for professional problems from community physicians. Send your submission of 750 words or less to Editor in Chief Charles J. Lockwood, MD, by e-mail Dr.Lockwood@advanstar.com
fax (973-847-5340) or mail (5 Paragon Drive, Montvale, NJ 07645). All submissions are subject to peer review by the Contemporary OB/GYN Editorial Board. Nevertheless, the concepts discussed may be anecdotal in nature.
REFERENCES1. Greenspoon JS, Kovacic A. Breech extraction facilitated by glyceryl trinitrate sublingual spray. Lancet. 1991;338:124-125.
2. DeSimone CA, Norris MC, Leighton BL. Intravenous nitroglycerine aids manual extraction of retained placenta. Anesthesiology. 1990;73:787.
3. Altabef KM, Spencer JT, Zindberg S. Intravenous nitroglycerine for uterine relaxation of an inverted uterus. Am J Obstet Gynecol. 1992;166:1237-1238.
4. Mayer DC, Weeks SK. Antepartum uterine relaxation with nitroglycerine at cesarean delivery. Can J Anesth. 1992;39:166-169.
Unlocking HPV prevention: Insights from 2022 data on vaccination trends
May 14th 2024Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.
Read More
Prenatal cannabis and nicotine use linked to adverse pregnancy outcomes
May 14th 2024A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.
Read More
Understanding pediatric STIs: Trends, management, and more
May 10th 2024Dive into the rising prevalence of sexually transmitted infections among adolescents and young adults, exploring educational gaps, vaccination rates, and the imperative need for open conversations between patients and health care providers to combat stigma and enhance preventive care.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More